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CBOLECALCIFEROL: A UNIQUE TOXIC.ANT FOR RODENT CONTROL 
EDWARD F. MARSHALL, Bell Laboratories, Inc., Madison, Wisconsin 53704 
ABSTRACT: Cholecalciferol is an acute (single-feeding) and/or chronic {multiple-feeding) rodenticide 
toxicant with unique activity for controlling corimensal rodents including anticoagulant-resistant rats. 
Cholecalciferol differs from conventional acute rodenticides in that no bait shyness is associated with 
consumption and time to death is delayed, with first dead rodents appearing 3-4 days after treatment. 
INTRODUCTION 
It has been well documented over the past two decades that corrmensal rodents are becoming more 
difficult to control with anticoagulant rodenticides {Jackson and Kaukeinen 1972). House mice have 
historically been more difficult to control with anticoagulants, including even the newer "second-
generation11 products, as they all function through the same biochemical pathway (Sul l 1983). 
Even before the introduction of newer, more potent, anticoagulants, research had been started by 
Bell Laboratories, Inc., to search for a replacement rodenticide that possessed many of the beneficial 
attributes of anticoagulants but with a mode of action unique to the compound. 
This work led to the careful review of cholecalciferol (Vitamin o3) as a possible rodenticide candidate. 
PHYSICAL CHARACTERISTICS 
Technical cholecalciferol is an amber crystalline solid. Cholecalciferol is practically insoluble 
in water, soluble in the usual organic solvents, and slightly soluble in vegetable oils. 
Molecular weight 384.62 
9,10-Secocholesta - 5,7,10(19)-trien-
38 - ol; activated 7 - dihydrocholesterol 
oo· 
EFFICACY 
In order to determine the efficacy of cholecalciferol on target commensal rodent species, 
toxicity. palatability and efficacy to target species needed to be established. 
Acute Oral Lo50 
Cholecalciferol was dissolved in corn oil and administered to the Norway rat and house mouse 
(Table l}. Oral toxicity values indicate cholecalciferol is toxic to target species with house mice 
being slightly more susceptible than Norway rats. 
Table 1. Acute Oral L050 (mg/Kg) for Cholecalciferol. 
Species 
Mus musculus 
Rattus norvegicus 
Efficacy/Palatability Studies 
Strain 
ICR 
Sprague-Dawley 
Sex 
M/F 
M/F 
42.5 mg/kg 
43.6 mg/kg 
Choice-feeding studies were conducted following the EPA acute dry bait test.p~otocol against . 
Norway rats, roof rats and house mice. Concentrations o'. 750 ppm (.075%) were ut1l~zed ~ased upon pr1or 
no-choice feeding trials (Kassa, Jackson 1978}. The cho1ce-test results are surrmar1zed ln Table 2. 
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(D.O. Clark. Ed.}. Printed at Univ. of Caltfomta. Davts. Calif. 
Mortality of 100% occurred with only three days' exposure to cholecalciferol. Average days until death 
ranged from 3.9 to 6.1 in mice, 3.3 to 4.7 in Norway rats, and 10.2 in roof rats. Cholecalciferol was 
readily accepted by the test animals, even when a palatable placebo test diet was available. There is 
no taste aversion to cholecalciferol and bait shyness is not apparent due to delayed toxic effects. 
Table 2. Choice efficacy studies with cholecalciferol bait. 
Cone. No. dead/ Avg. days 
% acceptance of 
chol ecalciferol 
S~ecies Strain ( rrnm) No. tested until death bait 
R. norvegicus Wi stal". 750 5/5 3.5 39.8 
I{. norve i cus Wis tar 750 10/10 3.7 61.1 it norve icus Wis tar 750 10/10 3.4 53.7 R. norvegicus Wistar 750 10/10 4.7 43. l R. norvegicus Wis tar 750 l 0/10 3.9 47.3 R. norvegicus Wistar 750 10/10 3.3 50.4 R. norvegicus Wis tar 750 10/10 3.5 43.3 R. norvegicus · Wistar 750 l 0/10 3.4 49.8 R. norvegicus Holtzman 750 10/10 4.4 41.5 R. norvegicus Wis tar 750 10/10 3·.6 52.8 R. norvegicus Wistar 750 10/10 3.7 45.8 R. norvegicus Wistar 750 10/10 3.5 38. l ]. norvegicus Wistar 750 10/10 3.3 52.8 
Mus musculus ICR 750 20/20 6. 1 44.6 
Mus musculus Swiss Webster 750 10/10 5.0 52.5 
Mus musculus ICR 750 10/10 4.3 48.0 
Mus musculus ICR 750 20/20 3.9 35.3 
Mus musculus ICR 750 10/10 4.3 39.5 
Mus musculus ICR 750 10/10 4.7 31.1 
Mus musculus ICR 750 10/10 4.3 31.8 
Mus musculus ICR 750 10/l 0 5.5 37. l 
B· rattus Wild 750 5/5 10.2 45.7 
Anticoagulant-Resistant Rats 
Anticoagulant-resistant Norway rats were obtatned from Dr. John Suttie, University of Wisconsin-
Madison. The resistant rats were acclimated to laboratory conditions for 14 days and maintained on 
a diet of Purina Rat Chow. 
The obtained anticoagulant-resistant rats were placed on the standard World Health Organization 
tests (WHO 1970) for warfarin resistance. After a 30-day cleansing period on a toxicant-free diet, the 
resistant rats were placed on the standard EPA acute dry bait test. Results- are su111T1arized in Table 3. 
Resistant rats showed no hesitation in accepting the cholecalciferol bait, killing 100% of the test 
animals with average day-to-death and consumption figures being similar to other choice feeding studies. 
Table 3. Choice-efficacy studies with cholecalciferol bait against Warfarin-resistant (WHO standard) 
rats. 
Species 
R. norvegicus 
E· norveqi cus 
TOXICOLOGY 
Hazard Evaluation 
Cone. No. 
(ppm} No. 
750 
750 
% acceptance of 
dead/ Avg. days chol ecal ci ferol 
tested until death bait 
20/20 4.3 43.6 
9/9 4.6 53.6 
Working with a human vitamin gave way to a considerable amount of chronic exposure data, but very 
little, if any. information was available on one single acute exposure to both humans and experimental 
animals. 
Crystalline cholecalciferol has a potency of 40,000,000 I.U./gram or 40 x 106 I.U./gram. Due to 
the instability of crystalline cholecalciferol, rgsinous material was chosen as the starting material 
with a potency of 28,000,000 l.U,/gram or 28 x 10 I. U./gram. 
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Cholecalcifer~l in the technical fonn. (~Ox 106 I.U./gram) is quite toxic; however, the toxicity 
is reduced proportionately as the concentrat1on of the active material is reduced. 
Du~ to the nature of the compound and physical characteristics of not only the technical material 
and res1nous concentrate, but also the fonnulation of the finished bait at 750 ppm cholecalciferol 
(.075%), sever~l _of the ~cu~e-hazard evaluation studies were waived by the U.S. Environmental Protection 
Agency. The finished bait 1s of low oral and dennal toxicity at concentrations tested (Table 4). 
Table 4. Acute Hazard Evaluation of Cholecalciferol. 
Test 
Oral (rats) Lo50 
Dermal {rabbits) Lo50 
Acute Nontarget Species Toxicity Studies 
100% Technical 
43.6 mg/kg 
.075% 
2,000 mg/kg. 
Acute-toxicity data were generated for cholecalciferol on nontarget species. It is known that 
Vitamin D2 is only 1-2 percent as potent for the chick as Vitamin D (Edes, personal correspondence). Because of this difference, the majority of current nontarget hazard evaluations have been conducted on 
avian species (Table 5). Results indicate that cholecalciferol is of low hazards to avian and canine 
species. 
Table 5. Cholecalciferol toxicity data from acute and short-term feeding studies to nontarget species. 
Species 
Dog - oral 
Mallard duck - oral* 
Mallard ducklings - dietary* 
Bob white quail - dietary* 
*studies conducted on 30% Concentrate (12 x 106 I.U./Gram). 
Secondary Toxicity 
88 mg/kg. 
2,000 mg/kg. 
4,000 ppm 
2,000 ppm 
Groups of Norway rats (Wistar strain) were fed free choice diets of .075% cholecalciferol bait 
versus EPA Challenge Diet following the TSO Designation 1.209(9-1-76} (Acute Dry Bait test protocol). 
It was determined that by following this test protocol would best simulate actual field conditions. All 
rats died from test diet ingestion, were skinned and the carcasses ground. The ground rats were 
packaged, labeled and frozen prior to being offered as dog food. 
Six beagle-type dogs (sexes equal} were acclimated to laboratory conditions for nine days prior to 
the initiation of the project. Test animals were fasted for 24 hours prior to test. All dogs were 
maintained on the test diet for 14 days or until death occurred. All test animals survived the 14 day 
no-choice feeding regime showing no signs of cholecalciferol intoxification or hypervitaminosis D. No 
pathologic abnormalities were noted. It was concluded that dogs consuming rats poisoned by cholecalci-
ferol did not receive a sufficient amount of toxicant to cause hypervitaminosis D even when fed a diet 
of poisoned rats exclusively for 14 days. It is reasonable to assume, therefore, that cholecalciferol 
does not pose a potential secondary hazard to canine species. 
MODE OF ACTION 
Cholecalciferol enters the body via oral ingestion and first accumulates in the liver. Here, the 
first metabolic change begins. An enzyme in the liver adds a hydroxl group (-OH} to the 25th carbon 
atom which is located in the side chain of the molecule {Deluca 1979). The product, commonly referred 
to as 25-0H-03 , is released into the blood stream where it is present in concentrations approximately 10 tines the revels of Vitamin 0. When there is a metabolic demand for calcium or phosphorus (blood 
levels fall), 25-0H-D3 is metabolized in the kidney where another enzyme adds a second hydroxyl group at the number 1 carbon atom. This is l ,25-(0H) 2 D and is considered to be the hormonal form of Vitamin D. It would be incorrect to imply that alf 25-0H-03 is converted to 1 ,25-(0H), D1 . Under physiological conditions where relatively little calcium is needed, such as with matur~ animals where 
maintenance is the factor, another kidney enzyme is activated to convert 25-0H-D1 to 24,25-(0H) 2 D3. This seems to be part of a slowdown or shutoff mechanism for calcium mobilization. 
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Major functions of Vitamin D in animal nutrition are known. Many critical reactions in the body 
require calcium. In addition to forming new bone, calcium is needed for the formation of egg shells. 
milk production, blood clotting, neuromuscular action and a host of other functions. It is not sur-
prising, therefore, that the pool of calcium circulating in the blood is very carefully regulated . In 
most nonavians, changes of more than 10-15% can be disastrous to the living system. Consequently, a 
sophisticated system involvin9 the intestines, kidneys and skeleton is primarily regulated by the 
hormones: parathyroid hormone (PTH), calcitonin, and 1 ,25-(0H)? o1 that generally keep blood calcium levels within 2-3% of nonnal. If calcium levels should fall nelow nonnal, the kidney is stimulated by 
PTH to produce l ,25-(0H) 2 o3. 
As l ,25-(0H) D levels rise, cells in the small intestine are stimulated to absorb more calcium 
and phosphorus. ~on~ is also mobilized in the presence of PTH and l ,25-(0H) 2 D to release calcium and phosphorus into the blood stream. These factors along with increased kidney re~bsorption of calcium 
tend to raise the blood calcium and phosphorus levels. If calcium levels in blood rise too much too 
rapidly, and the normal regulation by honnone activity fails to counteract the process, the net result 
is a system failure responsible for resulting calcification diseases including blockage of the circula-
tory system. This is the fatal action demonstrated in rodents that have consumed large doses of 
cholecalciferol as a rodenticide. Mortality in all animals is exhibited, but rodents succumb to lower 
doses than other animals simply because of their small size. The effect of raised blood calcium levels 
in malllTlalian and avian species is effectively regulated by the thyroid hormone, calcitonin, that is 
released to counteract the process initiated by PTH and 1,25-(0H) D . Hormones react rapidly in . ~ ... 
mammalian and avian species to keep blood and other critical flui~s 1ully saturated with calcium at 
normal levels to enable bone formation and other critical calcium reactions to occur on demand. 
CONCLUSION 
Cholecalciferol has been proven to be toxic and effective to target species, yet relatively safe to 
nontarget species if used according to label directions. 
Due to cholecalciferol 's unique mode of action, the product looks promising for use as a conmensal 
rodent control product, but due to its unique attributes (i.e. no taste aversion, delayed toxic effect) 
and vitamin status, future rodenticide applications for field rodents look promising. 
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